Profile ng asset

HT-001 · Rocket One Inc. (RKTO)

Indikasyon
mga dermatologic na toxicities na nauugnay sa mga therapy ng inhibitor ng EGFR para sa kanser
KumpanyaRKTORocket One Inc.

Rocket One Inc is focused on developing and commercializing infrastructure for the orbital economy, including next-generation nanomagnetic AI chip technology designed for radiation-tolerant, energy-constrained environments such as low-Earth orbit, deep-space p…

Nakarehistrong trial

Registry IDPhaseStatusPrimary completionEnrollmentSites
NCT05639933Phase 2Nagre-recruitDis 30, 20261529 sa 12 site ay nasa United States
HT-001 · Rocket One Inc. (RKTO) — FDA Timeline at Readiness Checklist | SimianX AI